FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292018431> ?p ?o ?g. }

• W4292018431 endingPage "194" @default.
• W4292018431 startingPage "189" @default.
• W4292018431 abstract "Polo-like kinase 4 (PLK4) plays an essential role in the tumorigenesis of some blood malignancies; consequently, we hypothesized that PLK4 might serve as a potential biomarker in childhood acute lymphoblastic leukemia (ALL) patients. Therefore, this study investigated the expression of PLK4 and its clinical relevance in childhood ALL patients. Bone marrow specimens were collected from 95 childhood ALL patients and 20 primary immune thrombocytopenia patients (as controls), and their PLK4 expression (reverse transcription-quantitative polymerase chain reaction) was measured after enrollment. Besides, the PLK4 expression in childhood ALL patients was also determined at day 15 after the initiation of induction therapy (D15). PLK4 was increased in childhood ALL patients compared with controls (2.830 (interquartile range (IQR): 1.890-3.660) versus 0.976 (IQR: 0.670-1.288), P ≤0.001). PLK4 at diagnosis was elevated in T cell acute lymphoblastic leukemia patients than in B cell acute lymphoblastic leukemia patients ( P =0.027). Besides, PLK4 at diagnosis was positively linked with the Chinese Medical Association risk stratification ( P =0.016), but not with prednisone response ( P =0.077) or bone marrow response ( P =0.083). In addition, PLK4 was decreased at D15 after treatment compared with at diagnosis ( P ≤0.001). Interestingly, PLK4 at D15 (P=0.033) was elevated in T cell acute lymphoblastic leukemia patients than in B cell acute lymphoblastic leukemia patients. Furthermore, increased PLK4 at D15 was associated with poor prednisone response ( P =0.018), poor bone marrow response ( P =0.034), and increased the Chinese Medical Association risk stratification ( P =0.015). In terms of prognosis, high PLK4 was associated with shorter event-free survival ( P =0.020), whereas it was not related to the overall survival ( P =0.135). In conclusion, PLK4 has the potential as a biomarker for treatment response and prognostic risk stratification of childhood ALL patients." @default.
• W4292018431 created "2022-08-17" @default.
• W4292018431 creator A5064393625 @default.
• W4292018431 creator A5089008822 @default.
• W4292018431 date "2022-08-11" @default.
• W4292018431 modified "2023-09-26" @default.
• W4292018431 title "Polo-like Kinase 4: the Variation During Therapy and its Relation to Treatment Response and Prognostic Risk Stratification in Childhood Acute Lymphoblastic Leukemia Patients" @default.
• W4292018431 cites W2017435982 @default.
• W4292018431 cites W2061443367 @default.
• W4292018431 cites W2105061669 @default.
• W4292018431 cites W2127954126 @default.
• W4292018431 cites W2154410907 @default.
• W4292018431 cites W2157912932 @default.
• W4292018431 cites W2434441622 @default.
• W4292018431 cites W2725970815 @default.
• W4292018431 cites W2769243422 @default.
• W4292018431 cites W2769823260 @default.
• W4292018431 cites W2794686680 @default.
• W4292018431 cites W2801457562 @default.
• W4292018431 cites W2804265396 @default.
• W4292018431 cites W2804365853 @default.
• W4292018431 cites W2887335753 @default.
• W4292018431 cites W2890168201 @default.
• W4292018431 cites W2915674725 @default.
• W4292018431 cites W2918708984 @default.
• W4292018431 cites W2999407263 @default.
• W4292018431 cites W3014584966 @default.
• W4292018431 cites W3083881843 @default.
• W4292018431 cites W3134178483 @default.
• W4292018431 cites W3135721309 @default.
• W4292018431 cites W3137644633 @default.
• W4292018431 cites W3173465116 @default.
• W4292018431 doi "https://doi.org/10.1097/mph.0000000000002520" @default.
• W4292018431 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35973104" @default.
• W4292018431 hasPublicationYear "2022" @default.
• W4292018431 type Work @default.
• W4292018431 citedByCount "0" @default.
• W4292018431 crossrefType "journal-article" @default.
• W4292018431 hasAuthorship W4292018431A5064393625 @default.
• W4292018431 hasAuthorship W4292018431A5089008822 @default.
• W4292018431 hasBestOaLocation W42920184311 @default.
• W4292018431 hasConcept C119060515 @default.
• W4292018431 hasConcept C126322002 @default.
• W4292018431 hasConcept C143998085 @default.
• W4292018431 hasConcept C203014093 @default.
• W4292018431 hasConcept C2776863199 @default.
• W4292018431 hasConcept C2778461978 @default.
• W4292018431 hasConcept C2778720950 @default.
• W4292018431 hasConcept C2780007613 @default.
• W4292018431 hasConcept C71924100 @default.
• W4292018431 hasConcept C90924648 @default.
• W4292018431 hasConceptScore W4292018431C119060515 @default.
• W4292018431 hasConceptScore W4292018431C126322002 @default.
• W4292018431 hasConceptScore W4292018431C143998085 @default.
• W4292018431 hasConceptScore W4292018431C203014093 @default.
• W4292018431 hasConceptScore W4292018431C2776863199 @default.
• W4292018431 hasConceptScore W4292018431C2778461978 @default.
• W4292018431 hasConceptScore W4292018431C2778720950 @default.
• W4292018431 hasConceptScore W4292018431C2780007613 @default.
• W4292018431 hasConceptScore W4292018431C71924100 @default.
• W4292018431 hasConceptScore W4292018431C90924648 @default.
• W4292018431 hasIssue "4" @default.
• W4292018431 hasLocation W42920184311 @default.
• W4292018431 hasLocation W42920184312 @default.
• W4292018431 hasLocation W42920184313 @default.
• W4292018431 hasLocation W42920184314 @default.
• W4292018431 hasOpenAccess W4292018431 @default.
• W4292018431 hasPrimaryLocation W42920184311 @default.
• W4292018431 hasRelatedWork W2045210690 @default.
• W4292018431 hasRelatedWork W2065008538 @default.
• W4292018431 hasRelatedWork W2067974345 @default.
• W4292018431 hasRelatedWork W2352793801 @default.
• W4292018431 hasRelatedWork W2357201540 @default.
• W4292018431 hasRelatedWork W2370729850 @default.
• W4292018431 hasRelatedWork W2372435973 @default.
• W4292018431 hasRelatedWork W2380660014 @default.
• W4292018431 hasRelatedWork W2410819865 @default.
• W4292018431 hasRelatedWork W2413329463 @default.
• W4292018431 hasVolume "45" @default.
• W4292018431 isParatext "false" @default.
• W4292018431 isRetracted "false" @default.
• W4292018431 workType "article" @default.